Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Commissioner Sid Miller secures donation of much-needed PPE for Rural Texas hospitals


News Image

“We would get reports from many sources ranking states performance at securing needed supplies. Nebraska was always at the top of the list. I’d heard they had a great procurement team up there, so when Yaniv told me he was already working with them, I wasn’t surprised.”

Today, Texas Commissioner of Agriculture, Sid Miller, who heads the Texas State Office of Rural Health, thanked Yaniv Sarig of Mohawk Group (NASDAQ: MWK) for their generous contribution of needed Personal Protective Equipment (PPE) for Texas’s 163 rural and community hospitals.

Often rural hospitals, the lifeline for non-urban portions of Texas, are overlooked when it comes to securing public safety equipment required for safe operations during the COVID-19 crisis.

Sarig said, “I was inspired by Commissioner Miller after watching his interview on 60 minutes last month discussing the unique struggles faced by rural healthcare providers and thought it would make sense to get on a call with him to see what we could do to help.”

At first glance, PPE procurement did not seem like a natural fit for Mohawk Group (NASDAQ:MWK), a tech-driven e-Commerce firm, “When COVID-19 erupted, our leadership team got together to discuss what we could do to help. As a fast growing e-Commerce company, we have built an incredibly agile supply chain capable of sourcing high quality goods from all over the world. With states and hospitals around the country urgently needing PPE from a trusted and capable partner, we believed it was our responsibility to rise to the challenge,” Sarig added.

Miller continued, “Mohawk Group, at Sarig’s direction, is donating to the TDA, one hundred thousand masks, which the department will distribute to rural and community hospitals throughout the State.” While Mohawk Group is based in New York City, they have come to the aid of rural Texans as well as rural citizens of other states.

Miller wasn’t surprised to learn Mohawk Group had already been working with another famously rural state, Nebraska. “We would get reports from many sources ranking states performance at securing needed supplies. Nebraska was always at the top of the list. I’d heard they had a great procurement team up there, so when Yaniv told me he was already working with them, I wasn’t surprised.” Miller chuckled.

In Nebraska, Mohawk Group worked closely with Doug Carlson, the State’s Chief Procurement Officer, to ensure that citizens of the Cornhusker State had access to needed PPE. This action resulted in that state successfully keeping COVID-19 transmissions to a minimum.

“While our country has been in turmoil and life upended, it has been gratifying to see American heroes, like Mr. Sarig and Mr. Carlson, step up and provide real-world common-sense solutions to problems. It takes people like this to cut through the bureaucratic overreach and incompetence during a time of crisis.” Miller said.

He added: “On behalf of the people of Texas, the TDA, State Office of Rural Health, and our state’s 163 rural hospitals, I want to sincerely thank Yaniv Sarig for his willingness to assist his fellow Americans in other states. He is a testament to the ingenuity and outside the box thinking that is the hallmark of American business and our free enterprise system.

Carlson echoed Miller in saying, “Without the support of American business leaders like Yaniv, rural Americans would have suffered and continue to suffer from the hardships created by an incompetent and often selfish and cumbersome bureaucracy.

“Mohawk Group demonstrated through their efforts in Texas, Nebraska, and others that the interest of socially responsible business leaders and community leaders can be aligned for the greater good of Americans,” said Miller.

Carlson added, “It was disheartening to see so many people trying to take advantage by irresponsibly and unethically promising life-saving equipment and then failing to deliver, or worse trying to sell fraudulent items. Their actions unnecessarily put lives at risk. I want to thank Yaniv Sarig and Mohawk Group. With Mohawk’s continued support and companies like them, I’m confident we will successfully weather this storm and ensure our state is prepared for the next one.”

Miller says, “It is fitting that as we just celebrated our nation’s independence and honor our cherished American institutions, we take this opportunity to honor the patriots of American business.”

Mohawk Group Holdings, Inc. is headquartered in New York City with approximately 140 employees around the world and is publicly traded on the NASDAQ (MWK). Mohawk is a fast-growing technology-enabled consumer products company. They have built a proprietary software platform to identify and predict consumer trends; they then use the insights discovered in the data to manufacture, import, and sell high demand consumer products online. They launched over 250 products since inception and are growing fast, with revenues of approximately $114M in 2019. They import millions of dollars of goods per month and have approximately 40 employees in Asia who are experts in sourcing, quality control, and logistics. As such, they are incredibly well-positioned to help in this crisis as the nature of the business is based on an agile supply chain and rapid procurement. They also can finance very large P/Os and QC inspect each production run meticulously (with their employees) to make sure that what is delivered meets the buyer’s standards.

Share article on social media or email:

NJ Top Dentist, Dr. Eugene A. Isola III Is Now Offering Digital Dentistry Options


Dr. Eugene A. Isola, III

Dr. Eugene A. Isola, III

NJ Top Dentist, Dr. Eugene A. Isola, III is now offering teledentistry appointments to his new and existing patients. As the COVID-19 pandemic has forced Dr. Isola’s practice to alter office hours and procedures, your oral health is still his number one priority.

Through his teledentistry services, you can now schedule video chats with Dr. Isola. This will allow him to diagnose whether you need emergency treatment, provide remote consultations and helps Dr. Isola to deliver any dental care his patients may need during this time.

While there is no substitute for seeing his patient’s smile in person, Dr. Isola’s practice is excited to provide this new option. Patients can schedule remote appointments just as they would an in-person visit.

Dr. Isola is also now offering online payment options and digital chat features.

Dr. Isola prides himself on remaining open throughout the entire COVID-19 pandemic for treating all of his patient’s emergency dental procedures. His goal is to keep his patients safe, healthy, and far away from hospitals.

To learn more about NJ Top Dentist, Dr. Eugene A. Isola please click here: https://njtopdocs.com/nj-dentists/eugeneisoladds/.

About Us

NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



The iaedp™ Foundation Launches Second Call for Proposals for 2021 Symposium; Final Deadline Is July 31, 2021


The International Association of Eating Disorders Professionals Foundation (iaedp™) is launching its Second Call for Proposals for the annual iaedp™ Symposium slated for February 17 – 21, 2021 The deadline for all 2021 proposals is July 31, 2020.

Next year’s iaedp™ Symposium will be held at the JW Marriott Desert Springs Resort & Spa. More information about the 2021 iaedp™ Symposium can be found at https://iaedp.confex.com/iaedp/2021/cfp.cgi.

The iaedp™ Foundation is pursuing abstracts in both English and Spanish on inventive and inclusive treatment modalities for the many phases of the journey for those with eating disorders — from denial and resistance to treatment and ultimately recovery. The group also requests treatment providers from all disciplines to convert their latest or ongoing research and treatment updates into meaningful eating disorder treatment protocols across populations.

Many of the professionals who submit proposals for the iaedp™ Symposium include experiential or interactive components in their presentations.

“Preference is given to unique presentations that are being offered for the first time,” says Bonnie Harken, Managing Director at iaedp™. “Individuals are limited to submitting a maximum of two proposals as a presenter or as a co-presenter. Multiple proposals may impact the review process as well as selection for presenting at the 2021 iaedp™ Symposium.”

About the iaedp™ Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp™ business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and international chapter activity and events; for more information, visit MemberSHARE.

The Presidents Council provides iaedp™ support and includes: Center for Change; Center for Hope of the Sierras; Center for Discovery; Eating Recovery Center; Willow Place; Laureate Eating Disorders Program; The Meadows Ranch; Rogers Behavioral Health; Rosewood Centers for Eating Disorders; Selah House; The Renfrew Center; Veritas Collaborative; Alsana Eating Disorder Treatment & Recovery Centers; Walden Behavioral Care and KIPU.

Share article on social media or email:

A Unique Virtual Journey through the World of Clinical and Regulatory Innovation, Sponsored by Phlexglobal


Our goal with the Innovation Tour is to promote the sharing of valuable knowledge gained by the people who live and breathe compliance in our industry every day. John McNeill, CEO

Phlexglobal, a leading innovative technology and services provider for the life sciences industry, today announces the launch of the Innovation Tour: a unique and virtual educational journey addressing challenges and solutions for effective regulatory compliance in life sciences. Bringing together clinical, regulatory and technology experts from leading pharmaceutical companies, technology innovators, and Phlexglobal’s own authoritative team, the Innovation Tour will provide a wealth of practical knowledge to industry practitioners.

The Innovation Tour kicks off on July 15, 2020 with a virtual panel featuring leaders in regulatory operations and IDMP from US and European pharmaceutical companies. Joined by Phlexglobal subject matter experts, the panelists will share IDMP preparation best practices and lessons learned.

The informative series continues with new, live virtual sessions held each week on topics including:

  • Aligning and automating submission and TMF processes and data
  • Validating artificial intelligence systems in clinical and regulatory
  • Best practices for TMF archiving to meet regulatory mandates
  • New approaches to collaborative TMF content management
  • How to align TMF outsourcing with sponsor goals

The Innovation Tour will continue into September with a panel discussion including TMF operational experts from Japanese and European pharmaceutical companies. Moderated by Phlexglobal, the panelists will examine innovative approaches to improving TMF management.

“Our goal with the Innovation Tour is to promote the sharing of valuable knowledge gained by the people who live and breathe compliance in our industry every day,” said John McNeill, Chief Executive Officer of Phlexglobal. “In the face of an evolving regulatory landscape and ongoing deluge of data, we wanted to provide valuable insights that people can take back and apply in their organizations immediately.”

A single registration conveniently provides access to all Innovation Tour sessions and content, both live and on-demand. And to foster knowledge-sharing and interaction, a unique platform of engagement options will include small breakout sessions and private networking events. Attendees who share their experiences will earn points for participating and contributing to the conversation, with potential awards ranging from a Sonos One speaker to an Apple iPad Pro.

To learn more about the Innovation Tour and to register, please visit https://innovationtour.phlexglobal.com/.

Share article on social media or email:

Regulation, Compliance, and Best Practices Webinar July 29, 2020


WCG FDAnews

WCG FDAnews

Searching for the best way to fulfill the competing needs of various device identification requirements? Looking for the most efficient way to appropriately identify a product in different global markets?

The task of meeting unique device identification (UDI) guidelines can be complicated. Requirements around the world are evolving and despite efforts by the Global Harmonization Task Force and International Medical Device Regulator Forum to integrate global expectations, they are evolving in different ways in different places.

Even now, when the deadline for final implementation of Class I products is quickly approaching in the United States and UDI timelines in the EU remain unchanged due to COVID-19, regulatory bodies in other countries are starting to implement their own new programs.

UDI expert Jay Crowley will share ways to manage multiple regulatory bodies, best practices around establishing and maintaining robust and effective global UDI processes, possible responses to distinct local UDI concerns and how to submit identification product data to various stakeholders:

The Evolution of Universal Device Identification Guidelines:


  • Impacts on device identification and product data
  • Global development and implementation of UDI requirements
  • Recommended shared data obligations

Intertwining Regulatory, Commercial and Patient-Safety Information:

  • How regulatory complexities affect device manufacturers
  • Ways manufacturers can work with stakeholders to guide and manage information
  • National and local regulatory concerns: counterfeits, traceability, cost controls

Initial Development, Maintenance and Reuse of Information:

  • Supporting global use-cases

UDI Best Practices:

  • EU UDI requirements, including EUDAMED expectations

Finding the best way to meet shifting global identification obligations is a complicated balancing act. Learn how to navigate the process and discover the most effective, practical solutions to international UDI concerns.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Meeting Global Unique Device Identification Requirements:

Regulation, Compliance, and Best Practices

An FDAnews Webinar

Wednesday, July 29, 2020, 1:30 p.m.-3:00 p.m. EDT

https://www.fdanews.com/udirequirements

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/udirequirements

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Unique Ziosoft AI Platform Exceeds 2,500 Installations in More Than 30 Countries Globally


The company will make free Covid-19 advanced visualization software available at no charge. Interested clinicians can visit Ziosoft’s virtual ECR booth #525 and request access to this software

Ziosoft, a pioneer in 3D/4D AI medical visualization, is featuring its comprehensive suite of advanced visualization and post-processing applications, on a true vendor neutral platform, at the annual European College of Radiology (ECR) being held virtually from July 15 – 19, 2020. With over 2,500 installations in 2,000 locations throughout more than 30 countries globally, the company is also highlighting PhyZiodynamics™ in Vivo, which enables virtual dynamic dissection to support precise therapy for organ targeting analyses and Implantations.

“PhyZiodynamics in Vivo offers an unprecedented “real-time” journey through the body non-invasively, supporting diagnoses and treatment planning for a wide variety of organ targets,” said Rajeev Taitriya, vice president, Business Development and Marketing for Ziosoft. “Whether for brain, lungs, or other regions of interest, PhyZiodynamics in Vivo, is an advanced 4D processing system, allowing the automated registration of DICOM-based modality images into true fidelity 3D and 4D organ data sets. These data sets then can be interactively interrogated throughout the entire structure while either still or in motion.”    

Taitriya also indicated the company will make free Covid-19 advanced visualization software available at no charge. Interested clinicians can visit Ziosoft’s virtual ECR booth and request access to this software.

Ziosoft’s AI platform provides a robust and clinically validated algorithm, which is driven by both a traditional and new era of machine learning, unlocking the potentials of artificial intelligence (AI) for efficient and repeatable outcomes. The company’s flagship Ziostation2 is an economical and scalable multi-departmental solution. A full suite of regulatory cleared 2D, 3D, and 4D analytical tools provides consistent functionality across the enterprise, without compromise. It provides a vendor-neutral advanced visualization platform across multiple imaging modalities. It is also based on architecture that is designed to grow with the future needs of clinicians.

“We use 20 plus years of medical imaging expertise with deep learning to enable accurate segmentation with easy-to-use intuitive tools for efficient and customizable workflows,” said Shusuke Chino, co-founder and president, Ziosoft. “This experience has not only brought outstanding 3D/4D to the radiological community, but several other useful tools including 3D printing which can be used in numerous planning endeavors. We look forward to continuing our ongoing developments to expand our AI-enabled visualization platform.”

About Ziosoft, Inc.

Ziosoft provides a comprehensive multi-modality, advanced processing and viewing solution for any specialty. Its customizable platform provides automated workflow to maximize efficiency. It is also a scalable, enterprise platform for “anywhere” accessibility and, as a software-only platform, it is simplified to minimize cost of ownership. For further information, visit http://www.ziosoftinc.com.

Share article on social media or email:

Navigating the Intersection Between Regulatory Requirements & Risk Management Webinar July 29, 2020


WCG FDAnews Logo

WCG FDAnews Logo

Pharmaceutical Quality Risk Management

Navigating the Intersection Between Regulatory Requirements & Risk Management

An FDAnews Webinar

Wednesday, July 29, 2020, 11:00 a.m.-12:30 p.m. EDT

https://www.fdanews.com/pharmaqrk

Risk is everywhere. And growing. Struggling to manage the types — and severity — of risk with Quality Risk Management (QRM) techniques?

QRM must be applied consistently to an ever-increasing roster of drug development, manufacturing, distribution, and inspection and submissions review processes. If one is exerting a huge effort but still feels adrift, this webinar is the answer.

Amanda McFarland, a QRM and microbiology senior consultant with ValSource, Inc., will explain the regulations relative to risk management and explain how to apply QRM’s principles to achieve compliance and maintain a competitive advantage. She will:


  • Discuss best practices related to QRM program development and execution, including process, people and documentation
  • Demonstrate ways to integrate QRM into quality systems such as change control and investigations and how integration can benefit an organization
  • Explore the PIC/S Aide-Memoire on QRM and how one can prepare for an inspection of a QRM program
  • Evaluate the risk management tools available to meet regulatory requirements, such as process hazard analysis (PHA), risk evaluation and mitigation (REM), hazard analysis critical control point (HACCP), and failure mode and effects analysis (FMEA)
  • Recognize the critical QRM regulations that apply to pharma such as ICH 9, ICH Q10, ISO 14644 and Annex 1

Given that organizations have made or are currently making decisions about how to maintain production levels in light of the novel coronavirus, this is an incredible opportunity: Ms. McFarland will assist one in exploring the risks and applying risk-based decisionmaking to ensure the long-term impacts of a company’s current decisions are fully understood.

Come away with the tools needed to ensure the QRM works to keep one compliant and moving forward.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.

Webinar Details:

Pharmaceutical Quality Risk Management

Navigating the Intersection Between Regulatory Requirements & Risk Management

An FDAnews Webinar

Wednesday, July 29, 2020, 11:00 a.m.-12:30 p.m. EDT

https://www.fdanews.com/pharmaqrk

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/pharmaqrk

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Genetic Editing Milestone in Mouse Model of Rett Syndrome


John Sinnamon, PhD and Gail Mandel, PhD

The study is the first example of RNA editing in a mouse model of a neurological disease, and therefore a considerable step forward in the potential of RNA editing becoming a therapeutic for Rett Syndrome,” Monica Coenraads, Rett Syndrome Research Trust

A genomic error that causes Rett Syndrome, a serious lifelong neurological disorder, can be corrected in the brains of mice by rewriting the genetic instructions carried by the RNA.

The new research, published July 14 in the journal Cell Reports, shows that RNA editing may repair the underlying cause of Rett Syndrome in a mouse model. The technology recoded enough RNA to restore half of the normal protein in three different kinds of neurons in the Rett mouse.

The results represent a promising early step in using RNA editing to treat Rett Syndrome, a disorder that affects about 350,000 individuals worldwide. The authors in the neuroscience lab of Gail Mandel at the Vollum Institute at Oregon Health and Science University (OHSU) in Portland, caution however, that much work lies ahead to advance the potential therapeutic to the clinic.

“This was a proof of principle” that the technique works in the brain, says lead author John Sinnamon.

People diagnosed with Rett Syndrome have mutations in a gene called MECP2. The gene makes a protein that is abundant in brain cells and controls the activity of many other genes.

Disease symptoms usually appear between 12 and 18 months of age and can include loss of speech and purposeful hand use, respiratory problems, motor deficits, seizures, and gastrointestinal and orthopedic issues. No cure exists, but studies in mice suggest restoring healthy MeCP2 protein function can dramatically reverse the condition.

Hundreds of different mutations in the MECP2 gene have been found in people with Rett Syndrome. The instructions for the protein it makes are coded in a unique combination of four genomic “letters” — A, C, G and T. The cell transcribes the DNA code into RNA and then into protein.

The idea behind the strategy used in this new study is to produce a healthy MeCP2 protein by repairing or “editing” the genetic error in the RNA.

The team used a mouse model of a human MECP2 mutation in which a single letter is wrong, an A where a G should be. They adapted an RNA editing technique by designing a guide to recognize the mutated section and change the A back to the normal G.

In 2017, Sinnamon, Mandel, and their colleagues reported their first success with the RNA approach, efficiently repairing the Rett mouse mutant RNA in developing neurons in a lab dish. In the new study, the team expanded on these results. They asked three questions: Is it possible to edit MeCP2 RNA in several different types of neurons in adult mice in vivo? If so, what types of neurons can be edited? Does editing restore MeCP2 protein function?

To address these questions, the researchers packaged a mouse Mecp2 RNA guide and human editing enzyme (the “editase”) in a viral vector and introduced it directly into the hippocampus, a well-studied brain structure associated with learning and memory.

The injected editase repaired about half of the RNA produced by the mutant MeCP2 gene in each of three types of neurons located in different regions of the hippocampus and, importantly, MeCP2 protein function was equally repaired in the neurons.

“It is encouraging that this RNA editing approach seems to be efficacious in different types of neurons in the brain,” says Mandel, the senior author whose lab has pioneered the concept of RNA editing in Rett Syndrome. A similar repair rate should be achievable throughout the brain, the researchers believe, if a vector can be delivered diffusely throughout the brain.

“In the next set of experiments,” Mandel says “we will administer the virus by blood, so that the entire brain is subject to editing. This will allow us to monitor whether there is any amelioration of Rett symptoms in the mice.”

As a strategy to restore the normal function of MECP2, the single-base RNA editing approach of swapping out A and G could address about 40% of all known mutations that cause Rett Syndrome, Sinnamon says.

The researchers reported that RNA of genes other than Mecp2 also were inadvertently edited, known as off-target effects. It is unknown what, if any, effect the off-target edits had in the mice. The experimental treatment appeared to cause no harm to the mice over the study time period.

As the RNA editing approach progresses through experimental steps, additional questions will need to be answered. “We need to know how much MECP2 RNA we need to repair in an individual cell and in how many cells in the nervous system,” Mandel says.

Her research group and others in the editing field also want to learn more about how to increase editing efficiency while diminishing off-target effects. “There are many bright and determined investigators working on these problems,” she says. “My hope is this paper will stimulate these creative minds even further. We are trying to take advantage of what’s happening in the field in real time and apply the emerging optimizations to Rett and other neurological diseases.

“The study is the first example of RNA editing in a mouse model of a neurological disease, and therefore a considerable step forward in the potential of RNA editing becoming a therapeutic for Rett Syndrome,” says Monica Coenraads, executive director of Rett Syndrome Research Trust, which helped fund the study. “Strategies that edit the mutation are an elegant way of addressing the problem. This exciting progress would not be possible without all of RSRT’s supporters and the affected families that are so dedicated to raising funds for us.”

RSRT funds six genetic approaches to restore a functioning MeCP2 protein in patients with disease causing mutations. Beyond RNA editing, other approaches are gene replacement, which is the closest to the clinic, gene editing, RNA trans-splicing, protein replacement and reactivation of the silent MeCP2 on the inactive X.

The study was funded by the Rett Syndrome Research Trust and the National Institutes of Health. Mandel is a scientific co-founder of Vico Therapeutics, a biotech company working on non-viral approaches to edit RNA in Rett syndrome and other neurological conditions.

About Rett Syndrome Research Trust

The Rett Syndrome Research Trust (RSRT) is a non-profit organization with a highly personal and urgent mission: a cure for Rett Syndrome and related MECP2 disorders. RSRT operates at the nexus of global scientific activity enabling advances in knowledge and driving innovative research. Since its founding in 2008, RSRT has awarded $66 million, all of it contributed by affected families and their networks, to leading scientists. To learn more, please visit http://www.reverserett.org.

Publication Link

https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30859-7

Barnet Dulaney Perkins Eye Center Ranked #1 Eye Care Center in 2020


Barnet Dulaney Perkins Eye Center

Barnet Dulaney Perkins Eye Center Ranked #1 Eye Care Center in 2020

“Our patients represent the focal point of our practice. We are honored to be recognized by the people and communities we serve every day,” said Shane Armstrong, Co-President of American Vision Partners.

Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, is happy to announce that they have once again been voted #1 Eye Care Center in Arizona by Ranking Arizona. This represents the 8th consecutive year that they have won this prestigious award.

Ranking Arizona allows people to submit nominations and votes for the best businesses in Arizona. Barnet Dulaney Perkins Eye Center has been named #1 Eye Center in Arizona since 2013.

Dr. Scott A. Perkins, a leading physician at Barnet Dulaney Perkins Eye Center and throughout the country, says, “It is a great honor to continue to be recognized every year by patients throughout the state. We pride ourselves in being able to provide people with compassionate expert care.”

For more than 35 years, doctors at Barnet Dulaney Perkins Eye Center have been focused on offering best-in-class service to their patients through leading-edge technology, experienced providers, and a genuine desire to help people see the world better.

“Our patients represent the focal point of our practice. We are honored to be recognized by the people and communities we serve every day,” said Shane Armstrong, Co-President of American Vision Partners.

To schedule an appointment, please call 602-955-1000. Additional information can also be found online at http://www.GoodEyes.com

About Barnet Dulaney Perkins Eye Center

The doctors at Barnet Dulaney Perkins Eye Center are recognized leaders in providing state-of-the-art medical and surgical eye care in Arizona for more than 35 years. Doctors at Barnet Dulaney Perkins Eye Center use the most advanced technologies and techniques to treat patients at all stages of life. Comprehensive eye health services are provided by nationally renowned specialists in multiple fields of ophthalmology, including cataract surgery, vision correction, cornea, retina, glaucoma, and oculoplastics. Patients can expect compassionate and convenient care from the doctors of any of the Barnet Dulaney Perkins Eye Center clinics. For more information, please visit http://www.GoodEyes.com.

About American Vision Partners

American Vision Partners (AVP) is one of the nation’s largest and fastest-growing eye care physician services organizations. AVP serves communities throughout Arizona, New Mexico, and Nevada with more than 125 nationally recognized doctors and 105 locations, including 58 full-time clinics, 28 satellite clinics, and 19 ambulatory surgical centers.

We partner with the most respected ophthalmology practices in the country and share a best-in-class management system, infrastructure, and technology to provide the highest-quality patient care. Our partner practices, including Barnet Dulaney Perkins Eye Center, Southwestern Eye Center, M&M Eye Institute, Abrams Eye Institute, Retinal Consultants of Arizona and Havasu Eye Center have on average been in practice for more than 35 years. For more information, please visit http://www.AmericanVisionPartners.com

Share article on social media or email:

The Charleston Tech Center to install medical-grade filtration system


News Image

997 Morrison Dr
Charleston, SC

“Our approach and early adoption of clean air technologies has been well received by our tech tenants, and we have continued to attract new companies throughout this crisis,” said Hand. “We are not aware of any other office buildings in the market with this technology.”

The system includes active electrostatic MERV 15 system-wide filtration, akin to what surgery centers and medical facilities routinely install to prevent the spread of airborne bacteria and viruses from room-to-room or patient-to-patient. A bank of UV lights will further treat air flow for any remaining pathogens and also reduce mold counts and dust, providing a much cleaner air system. The technology is A-rated by the Centers for Disease Control (CDC) and The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE).

“This is part of our overall response to the pandemic,” said John Hand, CEO of Iron Bridge Capital Partners, the lead developer of the Charleston Tech Center. “At first, we were asking how we could afford this system given where commercial construction costs are today and the six-figure price tag, but then as we thought it through, the question became, how can we afford not to install this system? I thought about if my company and employees were working here, or my wife or one of my daughters, I would want to take whatever steps we can to keep the building and the occupants safe. I asked one of our mechanical engineers — all things being equal, would you rather work in a building with this system or one without? He clearly preferred one with this system in place.”

In addition to the air treatment system, the Charleston Tech Center will also institute more traditional COVID-19 protocols, such as hand sanitizer stations in the lobby and at each elevator, add touchless faucets, establish limits on elevator occupancy, have recommended maximum occupancies for shared conference rooms, and strongly encourage mask use in all common areas.

Scheduled to open in Q4 2020, the Charleston Tech Center comprises 92,000 square feet, including office, first floor retail, a linear public park and an 812-space parking garage operated by the City of Charleston. “The personal safety of anyone who walks into the building will be paramount to us, both when the building opens and far into the future,” said Ernest Andrade, Executive Director of the Charleston Digital Corridor, the Charleston Tech Center’s anchor tenant. “We are extremely excited to offer this distinctive safety advantage to anyone who chooses our building as their workplace home.”

https://www.facebook.com/chstechcenter/

https://twitter.com/chs_tech_center

https://www.linkedin.com/company/charleston-tech-center

https://www.instagram.com/chstechcenter/?hl=en

About Iron Bridge Capital Partners, LLC

Iron Bridge Capital Partners, LLC is a real estate investment and development firm headquartered in Charleston, SC with operations in Atlanta, Guam and Saipan. Founded in 2001, Iron Bridge focuses on innovative projects that transform communities through positive local impact generally in concert with local states and municipalities.

Share article on social media or email: